Mirtazapin Arena (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapin Arena, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as a tablet for oral use. It treats major depressive disorder and depressive episodes associated with anxiety in adults.

GNH USA supplies Mirtazapin Arena as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mirtazapine is used to manage depressive disorders and associated anxiety symptoms.

- Major depressive disorder: alleviates depressive mood, loss of interest, and related symptoms. - Depressive episodes with anxiety: reduces anxiety, improves sleep and overall mood. - Depression with comorbid anxiety disorders: provides combined antidepressant and anxiolytic effects.

Mirtazapine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Sedation or drowsiness: feeling unusually sleepy. - Increased appetite/weight gain: heightened hunger and possible weight increase. - Dry mouth: reduced salivary flow. - Constipation: difficulty passing stools. - Dizziness: light‑headed sensation, especially when standing.

Serious or Rare Side Effects: - Agranulocytosis: severe drop in white blood cells, increasing infection risk. - Seizures: rare occurrence of convulsive episodes. - Severe hypotension: marked drop in blood pressure causing faintness. - Hepatic dysfunction: abnormal liver enzyme elevations. - Suicidal ideation: emergence or worsening of suicidal thoughts.

Before initiating therapy, consider the following safety measures.

- Assess suicidality: monitor for new or worsening suicidal thoughts. - Monitor weight and metabolism: watch for significant weight gain or metabolic changes. - Caution in hepatic impairment: adjust use if liver function is compromised. - Avoid abrupt discontinuation: taper gradually to reduce withdrawal symptoms. - Avoid concurrent MAO inhibitors: ensure a 14‑day washout period. - Store at room temperature: keep in the original pack, protect from moisture.

Mirtazapine can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis or serotonin syndrome. - Other serotonergic agents (e.g., SSRIs, SNRIs): increased serotonin syndrome potential. - CNS depressants (e.g., benzodiazepines, barbiturates): additive sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Antihypertensives: possible additive hypotensive effect. - Carbamazepine: may reduce mirtazapine plasma levels. - Alcohol: enhances sedative properties and impairs coordination.